Opportunities on the road to value-based payment for children with chronic respiratory disease

Katharine A Kevill1, Alia Bazzy-Asaad2, Susmita Pati1

  • 1Department of Pediatrics, Stony Brook University School of Medicine, Stony Brook, New York.

Pediatric Pulmonology
|December 19, 2018
PubMed

Insights

The US healthcare system is shifting from fee-for-service to value-based payment models, impacting children with chronic respiratory disease. This transition requires careful planning to ensure improved, not hindered, access to quality care.

Area of Science:

  • Health Services Research
  • Pediatric Healthcare
  • Healthcare Economics

Background:

  • The US healthcare system is transitioning from fee-for-service (FFS) to value-based payment (VBP) models, accelerated by the Affordable Care Act.
  • VBP models are projected to surpass FFS by 2020, significantly altering healthcare delivery.
  • The current FFS model has created a healthcare infrastructure misaligned with the needs of children with chronic respiratory disease.

Purpose of the Study:

  • To analyze the opportunities and risks of VBP models for children with chronic respiratory disease.
  • To illustrate current and evolving payment models through case studies.
  • To propose a novel framework for evaluating VBP models for this vulnerable population.

Main Methods:

  • Review of current and evolving healthcare payment models.
  • Analysis of limitations within existing payment structures.
  • Development of a conceptual framework for VBP evaluation using fictional case studies.

Main Results:

  • The shift to VBP presents both opportunities for better alignment with patient needs and risks of further misalignment if not carefully implemented.
  • Current VBP models may not adequately address the complex, heterogeneous care requirements of children with chronic respiratory disease.
  • Stakeholder input is crucial to prevent negative impacts on access to high-quality care.

Conclusions:

  • Value-based payment models offer a chance to redesign healthcare delivery for children with chronic respiratory disease.
  • A thoughtful, stakeholder-informed approach is necessary to ensure VBP models enhance, rather than compromise, care quality and access.
  • A novel evaluation framework is proposed to guide the development and implementation of effective VBP models for pediatric chronic respiratory conditions.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
728
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.5K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.7K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.2K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
650